epirubicin has been researched along with Connective and Soft Tissue Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bergemann, C; Felix, R; Lemke, AJ; Lübbe, A; Riess, H; Senfft von Pilsach, MI | 1 |
1 trial(s) available for epirubicin and Connective and Soft Tissue Neoplasms
Article | Year |
---|---|
MRI after magnetic drug targeting in patients with advanced solid malignant tumors.
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Breast Neoplasms; Contrast Media; Drug Delivery Systems; Epirubicin; Female; Ferrosoferric Oxide; Humans; Iron; Magnetic Resonance Imaging; Magnetics; Male; Middle Aged; Neoplasms, Connective and Soft Tissue; Neoplasms, Glandular and Epithelial; Oxides; Prospective Studies; Reproducibility of Results | 2004 |